Literature DB >> 15643279

Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers.

Abbey Dattilio1, Margaret A Vizzard.   

Abstract

PURPOSE: Studies suggest that protease activated receptors (PARs) are mediators of inflammation and repair. Studies suggest a neurogenic mechanism for PAR2 in inflammation and the fact that interaction between PAR2 and transient receptor vanilloid receptor (TRPV1 or VR1) are important for the induction and maintenance of inflammatory pain.
MATERIALS AND METHODS: We examined the expression of PAR2 to 4 in bladder urothelium and detrusor muscle whole mounts in controls, female rats and those treated with cyclophosphamide (CYP) acutely (4 and 48 hours) or chronically (every third day for 10 days) using Western blot and immunohistochemical techniques. Colocalization of PARs in nerve fibers and VR1 immunoreactive nerve fibers was determined by double labeling techniques for protein gene product and capsaicin receptor (VR1).
RESULTS: Western blot revealed up-regulation (1.5 to 9.4-fold) of PAR2 to 4 in bladder after cystitis. Immunohistochemistry revealed PAR2 to 4 expression in urothelial and detrusor muscle cells, and in nerve fibers in the subepithelial bladder layer. Confocal microscopy revealed colocalization of PAR2 to 4 with protein gene product 9.5 and VR1, suggesting that PARs are distributed in C-fiber bladder nerves.
CONCLUSIONS: These studies demonstrate that 1) CYP induced cystitis up-regulates PAR2 to 4 expression in the bladder, 2) PAR2 to 4 is expressed in urothelium, detrusor muscle and bladder nerve fibers in control and CYP treated rats, and 3) bladder C-fibers and bladder afferent cells in dorsal root ganglia express PAR2 to 4. These results suggest the involvement of PARs in bladder inflammation that contributes to altered sensory processing and reflex function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643279     DOI: 10.1097/01.ju.0000143191.55468.1d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

Review 1.  Proteinase-activated receptors in the lower urinary tract.

Authors:  James D Moffatt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-02-10       Impact factor: 3.000

Review 2.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

Review 3.  TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications.

Authors:  António Avelino; Francisco Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-24       Impact factor: 3.000

4.  Protease-activated receptors as therapeutic targets in visceral pain.

Authors:  Nicolas Cenac
Journal:  Curr Neuropharmacol       Date:  2013-12       Impact factor: 7.363

Review 5.  Receptors, channels, and signalling in the urothelial sensory system in the bladder.

Authors:  Liana Merrill; Eric J Gonzalez; Beatrice M Girard; Margaret A Vizzard
Journal:  Nat Rev Urol       Date:  2016-03-01       Impact factor: 14.432

Review 6.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

7.  Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

Authors:  Graeme S Cottrell; Silvia Amadesi; Stella Pikios; Eric Camerer; J Adam Willardsen; Brett R Murphy; George H Caughey; Paul J Wolters; Shaun R Coughlin; Anders Peterson; Wolfgang Knecht; Charalabos Pothoulakis; Nigel W Bunnett; Eileen F Grady
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

8.  Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis.

Authors:  Ruhin Yuridullah; Kimberly A Corrow; Susan E Malley; Margaret A Vizzard
Journal:  Auton Neurosci       Date:  2006-05-02       Impact factor: 3.145

Review 9.  Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis.

Authors:  Naoki Yoshimura; Tomohiko Oguchi; Hitoshi Yokoyama; Yasuhito Funahashi; Satoru Yoshikawa; Yoshio Sugino; Naoki Kawamorita; Mahendra P Kashyap; Michael B Chancellor; Pradeep Tyagi; Teruyuki Ogawa
Journal:  Int J Urol       Date:  2014-04       Impact factor: 3.369

10.  TRPV1: a target for next generation analgesics.

Authors:  Louis S Premkumar; Parul Sikand
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.